1 / 18

SNP Genotyping and Analysis Market Analysis | Coherent Market Insights

Read here the market research report on u201cSNP Genotyping and Analysis Marketu201d published by CMI team.

athiranair23
Télécharger la présentation

SNP Genotyping and Analysis Market Analysis | Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market InsightS Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. SNP Genotyping and Analysis Market Analysis (2020-2027) • Single Nucleotide Polymorphism (SNP) represents the most common type of mutation in genomes of all life forms. SNP genotyping is the measurement of genetic variations of SNPs between members of a species. • The global SNP genotyping and analysis market is estimated to account for US$ 11,553.0 Mn in terms of value in 2020 and is expected to reach US$ 46,268.9 Mn by the end of 2027.

  3. Global SNP Genotyping and Analysis Market: Drivers • Increasing prevalence of genetic disorders is expected to propel growth of the global SNP genotyping and analysis market over the forecast period. For instance, according to Summary of the Cystic Fibrosis Foundation Patient Registry, 2003–2018, the number of people with cystic fibrosis increased from 21,421 in 2003 to 30,775 in 2018. • Moreover, collaborative efforts to enhance personalized medicine is also expected to aid in growth of the market. For instance, in April 2020, Indivumed GmbH, an oncology company, launched the Oncology Alliance for Individualized Medicine, an international collaborative alliance to advance personalized medicine in cancer through IndivuType, the company’s multi-omics database.

  4. SNP Microarray held dominant position in the global SNP genotyping and analysis market in 2019, accounting for 37.9% share in terms of value, followed by Taqman Allelic Discrimination and Others, respectively.

  5. Figure 1. Global SNP Genotyping and Analysis Market Share (%), by Value, by Technology, 2019

  6. Global SNP Genotyping and Analysis Market: Restraints • Imperfect protocols leading to large redundant data are expected to hinder growth of the market. Several areas such as diagnostics within the genotyping segment are currently yet to reveal themselves as potential markets. Although diagnostics has been closely associated with SNP genotyping, currently the genotyping technique only serves as a research tool in diagnostics instead of being able to conduct a diagnostic test. • Moreover, despite the high accuracy of short read sequencing, there are still issues with attaining accurate SNP genotypes at low sequencing coverage and in highly duplicated genomes due to misalignment, which is also expected to limit growth of the market.

  7. Global SNP Genotyping and Analysis Market: Opportunities  • Increasing adoption of SNP genotyping in farm animal gene exploration is expected to offer lucrative growth opportunities for players in the global SNP genotyping and analysis market. For instance, in April 2020, researchers from Jung P & C Institute, Inc., South Korea, used Bayesian methods under different genotyping platforms to perform genomic analysis in Korean Duroc pigs. • Moreover, genomic, retrospective, multicenter analysis of cancer is also expected to aid in growth of the market.

  8. For instance, in June 2020, a study presented via the virtual Society of Gynecologic Oncology 2020 Annual Meeting on Women's Cancer, reported examining a large clinical dataset of low-grade serous ovarian cancer through the Ovarian Cancer Association Consortium, with the primary goal of identifying factors that affect survival. • The global SNP genotyping and analysis market was valued at US$ 9,485.2 Mn in 2019 and is forecast to reach a value of US$ 46,268.9 Mn by 2027 at a CAGR of 21.9% between 2020 and 2027.

  9. Global eHealth Software and Services Market: Opportunities  • Launch of telemedicine programs is expected to offer lucrative growth opportunities for players in the global eHealth software and services market. For instance, in March 2020, UK HealthCare launched a new telemedicine program to help prevent the spread of the novel coronavirus. • Moreover, increasing adoption of cloud-based PACS is also expected to aid in growth of the market. Cloud-based PACS offers several benefits such as on-demand self-service, broad network access, resource pooling, rapid elasticity, and measured service. • The global eHealth software and services market was valued at US$ 187.7 Bn in 2019 and is forecast to reach a value of US$ 458.3 Bn by 2027 at a CAGR of 11.8% between 2020 and 2027.

  10. Figure 2. Global SNP Genotyping and Analysis Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

  11. Market Trends/Key Takeaways • Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in February 2020, Fluidigm Corporation acquired InstruNor AS, a privately held provider of fully integrated sample preparation system for flow and mass cytometry. • Major players in the market are focused on investing in targeted therapies. For instance, in October 2018, Thermo Fisher Scientific facilitated the next phase of the FinnGen precision medicine study that aims to deepen the overall understanding of chronic disease mechanisms in the Finnish population.

  12. Global SNP Genotyping and Analysis Market: Competitive Landscape • Major players operating in the global SNP genotyping and analysis market include, LGC Limited, Fluidigm Corporation, Illumina, Inc., Life Technologies Corporation, PREMIER Biosoft, Thermo Fisher Scientific, and Sequenom, Inc.

  13. Global SNP Genotyping and Analysis Market: Key Developments • Major players in the market are focused on launching new products to expand their product portfolio. For instance, in July 2019, Thermo Fisher Scientific launched three new Applied BiosystemsAgriSeq targeted genotyping by sequencing solutions that will allow customers to genotype canines and felines.

  14. Request sample copy here • Request PDF brochure here • Request Customization here • Talk to Analyst • Buy Now • Reference: • https://www.coherentmarketinsights.com/market-insight/snp-genotyping-and-analysis-market-3972

  15. About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. • What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  16. Contact Us: • Mr. Shah • Coherent Market Insights Pvt. Ltd. • Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S. • Phone: +1-206-701-6702 • Email :sales@coherentmarketinsights.com

  17. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related